TABLE 2.
Age at inoculation (days) | Spleen no. | Proportion of assay mice with scrapie pathologya | Incubation period (mean ± SEM) (days) | No. of pathology negative assay mice after 400 days | Estimated titer (log10 i.c. ID50 units/g)b |
---|---|---|---|---|---|
0-1 | 1 | 0 | 9 | ||
2 | 0 | 11 | |||
3 | 0 | 8 | |||
4 | 10/10 | 242 ± 5 | 0 | 4.5 | |
5 | 0 | 12 | |||
6 | 10/10 | 242 ± 8 | 0 | 4.5 | |
10 | 7 | 11/11 | 221 ± 6 | 0 | 5.6 |
8 | 12/12 | 206 ± 8 | 0 | 6.4 | |
9 | 11/11 | 195 ± 3 | 0 | 7.0 | |
10 | 12/12 | 197 ± 2 | 0 | 6.9 | |
14 | 11 | 11/11 | 209 ± 6 | 0 | 6.2 |
12 | 10/10 | 224 ± 6 | 0 | 5.4 | |
13 | 12/12 | 207 ± 6 | 0 | 6.3 | |
14 | 12/12 | 198 ± 4 | 0 | 6.8 | |
29 | 15 | 10/10 | 215 ± 8 | 0 | 5.9 |
16 | 12/12 | 199 ± 3 | 0 | 6.8 | |
17 | 10/10 | 199 ± 4 | 0 | 6.8 | |
18 | 11/11 | 190 ± 4 | 0 | 7.2 |
Mice dying of intercurrent disease before 160 days postinjection and mice for which no pathology report was possible are excluded from the data.
Limit of the assay was approximately 3.0 log10 i.c. ID50 units/g.